- Overview
- Products
- 3M™ Littmann® Stethoscopes
- Medical Tapes
- Perioperative
- Skin Protection
- Sterilization
- Skin preparation
- Temperature Management
- Vascular Access
- Wound Management
- View All
- Conditions
- Bloodstream Infections (BSI)
- Incontinence-Associated Dermatitis (IAD)
- Lymphedema And Chronic Edema
- Medical Adhesive-Related Skin Injuries (MARSI)
- Pressure Injuries (PI)
- Radiation Therapy
- Surgical Site Infections (SSI)
- Venous Leg Ulcers (VLU)
- Diabetic Foot Ulcers (DFU)
- View All
- Education
- Support
Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully.
Prevena Central for Cardiothoracic Surgery
Convenient. Curated. Connected. Training for the use of 3M™ Prevena™ Therapy in cardiothoracic surgery.
-
75% reduced rate of SSI compared to standard of care1
90-day post-operatively 4% (3/75) Prevena Therapy vs 16% (12/75) SOC (p=0.0266)*
-
90% reduced rate of wound infection with gram-positive skin flora1,*
90-day post-operatively 1.3% (1/75) Prevena Therapy vs. 13.3% (10/75) SOC (p=0.0090)*
-
99% primary wound closure at day 6/7 on removal2,*
30-day post-operatively 98.7% (234/237) Prevena Therapy
-
75% reduced rate of SSI compared to standard of care1
90-day post-operatively 4% (3/75) Prevena Therapy vs 16% (12/75) SOC (p=0.0266)*
-
90% reduced rate of wound infection with gram-positive skin flora1,*
90-day post-operatively 1.3% (1/75) Prevena Therapy vs. 13.3% (10/75) SOC (p=0.0090)*
-
99% primary wound closure at day 6/7 on removal2,*
30-day post-operatively 98.7% (234/237) Prevena Therapy
-
75% reduced rate of SSI compared to standard of care1
90-day post-operatively 4% (3/75) Prevena Therapy vs 16% (12/75) SOC (p=0.0266)*
-
90% reduced rate of wound infection with gram-positive skin flora1,*
90-day post-operatively 1.3% (1/75) Prevena Therapy vs. 13.3% (10/75) SOC (p=0.0090)*
-
99% primary wound closure at day 6/7 on removal2,*
30-day post-operatively 98.7% (234/237) Prevena Therapy
Calculations are derived based on relative patient group incidence rate reported in this study.
*Statistically significant (p<0.05).
1. Grauhan O, et al. Prevention of post sternotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
2. Grauhan O, et al. Effect of surgical incision management on wound infections in a post sternotomy patient population. Int Wound J. 2014;11:6-9.
Proactive Risk Management (PRM) with Prevena Therapy
Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in cardiothoracic surgery.
-
Find detailed information about clinical studies for the use of Prevena Therapy in cardiothoracic surgery, including outcomes and cost-effectiveness.
-
Download the summary of findings for the use of Prevena Therapy following sternotomy surgery.
-
View an illustrative guide to aid in risk stratification for cardiothoracic surgery.
Learn more about the use of Prevena Therapy in cardiovascular surgery or request a product demonstration.
The 3M™ Prevena™ Incision Management System and 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of closed surgical incisions and surrounding intact skin in patients at risk for developing post-operative complications, such as infection, by maintaining a closed environment via the application of a negative pressure wound therapy system to the incision. The 3M™ Prevena™ Dressing skin interface layer with silver reduces microbial colonization in the fabric.
NOTE: Specific indications, limitations, contraindications,warnings, precautions, and safety information exist for these products and therapies. Please consult a clinician and product Instructions for Use prior to application. This material is intended for healthcare professionals only.
